Ampliphi Biosciences (NYSEAMERICAN:APHB) Shares Cross Below Fifty Day Moving Average – What’s Next?

Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s share price crossed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $3.83 and traded as low as $3.54. Ampliphi Biosciences shares last traded at $3.72, with a volume of 105,069 shares changing hands.

Ampliphi Biosciences Stock Up 4.0%

The stock has a fifty day moving average of $3.83 and a 200-day moving average of $6.83.

About Ampliphi Biosciences

(Get Free Report)

AmpliPhi Biosciences was a clinical-stage biotechnology company developing bacteriophage-based therapies for bacterial infections, including infections caused by antibiotic-resistant bacteria. Bacteriophages are viruses that target and infect specific bacteria, and the company pursued them as a potential complement or alternative to conventional antibiotics. Its investigational programs included AB-PA01, a bacteriophage cocktail targeting Pseudomonas aeruginosa, and AB-SA01, aimed at Staphylococcus aureus.

Further Reading

Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.